Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Pancreatic Neoplasms × ALT-803 × Clear all

Phase

Status

Terminated 5 Withdrawn 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2 Sarcoma, Synovial 1 Pancreatic Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Lymphoma, B-Cell 1 Liposarcoma, Myxoid 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 20 irinotecan sucrosofate 7 130-nm albumin-bound paclitaxel 7 Oxaliplatin 6 Leucovorin 6 Fluorouracil 6 Taxes 5 Drug Therapy 5 toripalimab 3 S 1 (combination) 3 Paclitaxel 3 Injections 3 Albumin-Bound Paclitaxel 3 surufatinib 2 camrelizumab 2 Radiosurgery 2 Pancreaticoduodenectomy 2 Irinotecan 2 Capecitabine 2 Blood Specimen Collection 2 zimberelimab 1 sintilimab 1 potassium oxonate 1 pembrolizumab 1 nimotuzumab 1 netrin-1 inhibitor NP137 1 gimeracil 1 folfirinox 1 disitamab vedotin 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07488884 2026-03-23

ResQ108B-PANC

ImmunityBio, Inc.

Phase 1 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡